AŁAdam Łabuda

Adam Łabuda

*This is an algorithmically generated author record based on publicly available information.

Adam Łabuda has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Systemic use of glucocorticoids in the treatment of sciatica – a review

    by Alicja Stępień, Adam Łabuda

    Sciatica is a common pain syndrome caused by compression of nerve roots at the L4/L5 or L5/S1 vertebral levels, most frequently due to intervertebral disc herniation. Symptoms include sharp pain radiating from the lumbar region through the buttock, the posterior and lateral thigh and lower leg, and down to the toes, along with sensory disturbances and muscle weakness. Treatment typically begins with conservative methods, primarily pharmacotherapy. Depending on pain severity, physical therapy is also recommended. In most cases, these approaches are sufficient. Epidural administration of glucocorticoids is one treatment option that has been shown to be effective for pain relief, particularly in the short-term. If there is no improvement, surgical intervention is considered. In Poland, single intramuscular or intravenous injections of dexamethasone are commonly used; however, the lack of scientific consensus prevents this method from being recognised as a standard treatment. The aim of this article is to evaluate the efficacy and rationale for the use of systemic use of glucocorticoids in the conservative treatment of sciatica. Studies on systemic glucocorticoid treatment show improvement in some patients, but the results remain inconclusive. Limitations include low statistical power due to small patient groups, inconsistent therapy protocols, and short follow-up periods. Systematic reviews and guidelines from international medical organisations suggest alternative therapeutic approaches, and systemic glucocorticoid use is generally not recommended for the treatment of sciatica. Therefore, continued research into this treatment method is necessary. Until more reliable data become available, it is advisable to follow current guidelines and the conclusions of meta-analyses.


  • Open Access

    The role of Artificial Intelligence in detecting breast lesions using ultrasound

    by Daria Ziemińska, Karina Motolko, Rafał Burczyk, Konrad Duszyński, Elżbieta Tokarczyk, Martyna Michalska, Adam Łabuda

    Introduction and objective: Breast cancer is the most diagnosed cancer and the second leading cause of cancer deaths in women globally, with rising cases and mortality. Early detection via mammography, ultrasound, or MRI is vital, with ultrasound excelling in dense breast tissue due to its safety and accuracy.Review methods: A literature review utilizing databases like Scopus, Google Scholar, and PubMed, with keywords such as "AI use in radiology" and "BI-RADS scale" underscores the need for advancements in understanding and managing graft rejection.Brief knowledge status: AI develops systems that simulate human intelligence, excelling in breast imaging by detecting patterns and providing accurate results. Machine learning (ML) and deep learning (DL) drive advances, with DL's CNNs leading in image analysis. AI aids BI-RADS lesion classification, ultrasound lesion detection, lymph node analysis, and treatment response prediction, often surpassing radiologists. Its future relies on real-world validation, improved outcomes, and clinical integration.Discussion: The integration of artificial intelligence (AI) into breast imaging marks a transformative leap in diagnostic radiology, enhancing precision, efficiency, and scalability. Driven by advancements in machine learning (ML) and deep learning (DL), AI excels in analyzing complex datasets. However, its clinical adoption requires addressing key considerations with a nuanced approach.Summary: In conclusion, AI holds immense promise in breast imaging, poised to redefine the field through enhanced diagnostic capabilities and clinical utility. Continued advancements and validation efforts will ensure its broader acceptance and sustained impact in medical imaging.

  • Open Access

    Current recommendations in Poland for vitamin D supplementation.

    by Jakub Kuciński, Zuzanna Fryska, Adam Wołejko, Paweł Semeniuk, Rafał Burczyk, Natalie Górna, Adam Łabuda, Ewelina Mazurek

    Introduction and objective: Vitamin D is a group of steroidal compounds that play an important role in calcium and phosphate metabolism. It exists in two forms, as ergocalciferol and cholecalciferol. Its deficiency is widespread globally, including Poland, especially during the autumn-winter...


  • Open Access

    Celiac disease and non-celiac gluten sensitivity – characteristics and differences

    by Kacper Kulik, Zuzanna Fryska, Adam Wołejko, Jakub Kuciński, Paweł Semeniuk, Krystian Matusz, Rafał Burczyk, Natalie Górna, Adam Łabuda

    Introduction Celiac disease is a quite common condition resulting from the interaction of genetic, immunological, and environmental factors, with the main environmental factor being exposure to gluten. Non-celiac gluten sensitivity (NCGS) affects individuals without celiac disease or wheat allergy and is characterized by intestinal and extraintestinal symptoms related to the consumption of grain products, without accompanying damage to the intestinal mucosa. Discussion Gluten is a grain protein that is resistant to digestive enzymes and accumulates in the intestines, leading to tissue damage and the release of tissue transglutaminase 2 (tTG2) enzyme, which increases gluten immunogenicity. The presence of HLA-DQ2 or HLA-DQ8 gene variants in the genome is a necessary condition for the development of the disease, but it does not always lead to celiac disease. The pathomechanism of non-celiac gluten sensitivity is not yet fully understood. Diagnosis of celiac disease involves serological tests, genetic tests, and histological examination. Conclusions The only effective treatment for celiac disease is a strict gluten-free diet, which involves eliminating wheat, rye, barley, and triticale from one's diet. Further research is necessary to search for effective therapies. The approach for NCGS involves introducing an appropriate diet - either low FODMAP or gluten-free.